Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Parasit Dis ; 42(2): 232-242, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29844628

ABSTRACT

Trichinosis is a sharable parasitic disease caused by Trichinella spp., the disease occurred on eating inappropriate cooked pork infected by the parasite encysted larvae. This study aimed to evaluate experimentally the impact of treatment by thiabendazole, praziquantel (PZQ) and prednisone on T. spiralis induced parasitological, serological and apoptotic changes. Forty albino rats were infected orally each by ± 1000 larvae, divided into four groups each of 10 rats, group (A) infected control, group (B) thiabendazole tested, group (C) PZQ tested and group (D) prednisone tested. On the seventh and 40th days post-infection, all groups were evaluated parasitologically by the number of the intestinal worms and the muscular encysted larvae, while IFN-γ and TNF-α were estimated by ELISA, histopathological and histochemical assessment of the tissue changes during both phases were performed by different stains. In conclusion, thiabendazole was a potent and curable drug, it showed nearly 100% efficacy on intestinal worms, highly significant variations in cytokines levels during both the intestinal and muscular phases, while it induced moderate effects on encysted muscular larvae number, In addition it ameliorated myocytes apoptotic changes induced by trichinosis.

2.
J Parasit Dis ; 42(2): 277-286, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29844633

ABSTRACT

Some reports have shown that mesenchymal stem cells (MSCs) therapy could ameliorate chemically-induced hepatic fibrosis. This research assesses the therapeutic action of bone marrow mesenchymal stem cells (BM-MSCs) on chronic diseased liver in Schistosoma mansoni infected mice. All infected female mice divided into three groups, one group (15 mice) treated with oral praziquantel (PZQ), second group (15 mice) received intravenous injection of BM-MSCs and third group (15 mice) treated with both MSCs + PZQ. Two control groups (15 mice each) subdivided into one infected and second healthy one. BM-MSCs were obtained from bones of both femur and tibia of male mice (30 mice), then cultured and characterized morphologically by detection of CD105 by flow cytometer. Liver tissues for all groups were examined histopathologically. Measuring of the collagen 1 gene expression was done by real-time PCR and immunohistochemical study to detect stem cells differentiation for detection of MSCs engraftments in liver tissue. MSCs treatment caused marked improvement and regression of fibrosis, and prevents deposition of collagen and reduced the expression of collagen 1 gene in infected mice on their liver tissues, especially when used with PZQ in mice treatment. It can be concluded that, MSCs is a good therapeutic method for liver fibrosis caused by S. mansoni infection.

3.
J Egypt Soc Parasitol ; 46(3): 693-716, 2016 Dec.
Article in English | MEDLINE | ID: mdl-30230766

ABSTRACT

Vaccination against schistosomes can be targeted towards the prevention of infection and/or to the reduction of parasite fecundity and pathology. However, as eggs are responsible mainly for schistosomiasis pathology, so crude soluble egg antigen (SEA) seems suitable to be used as a potential vaccine. Many studies have provided new insights establishing a role for mesenchymal stem cells (MSCs) in liver regeneration and improvement of schistosomiasis hepatic fibrosis, in addition to the need for standardized and effective adjuvant-vaccine formulations. So, the aim of this work is to evaluate the effect of stem cells when used as an adjuvant of a potential anti-schistosomal vaccine (crude SEA) in murine models. The current work was carried out on 100 mice (30 males for harvesting MSCs + 70 females for seven study groups, each of 10). A schedule of vaccination and challenge infection was followed so, GI (control healthy), G2 (control infected only) infected subcutaneously with S. mansoni cercaria (80-90 Schistosoma mansoni cercariae suspended in 0.2 ml distilled Water), G 3 (FCA then infected) received Freund's complete adjuvant (FCA) then infected, G4 (MSCs then infected) received MSCs then infected, G5 (SEA then infected) received SEA vaccine then infected, G6 (SEA+FCA then infected) received SEA vaccine and FCA then infected, G7 (SEA+MSCs then infected) received SEA vaccine and MSCs then infected. The current work was assessed by histopathological study and morphometric analysis (using H&E and Masson's Trichrome stains) to highlight number, size and type of liver granulomas and percentage of liver fibrosis, immunological and molecular studies (RNA extraction, Re- verse Transcriptase and PCR technique) for detection of interleukin-10 mRNA gene expression in liver tissue by reverse transcriptase & polymerase chain reaction (RT & PCR). The results showed that a- SEA alone as a potential anti-schistosomal vaccine was more or less moderately protective, b- MSCs alone before the infection had mild prophylactic effects, c- MSCs as an adjuvant of the crude SEA increased its capabilities with highly significant results regarding the decrease in granuloma number, size, percentage and density of hepatic fi- brosis, and d-There was significant increase in IL-10 mRNA gene expression on using (SEA+MSCs) (G7) if compared to other tested groups.


Subject(s)
Mesenchymal Stem Cells , Protozoan Vaccines/immunology , Schistosomiasis mansoni/prevention & control , Animals , Biomarkers/blood , Bone Marrow Cells , Female , Gene Expression Regulation/drug effects , Interleukin-10/genetics , Interleukin-10/metabolism , Male , Membrane Proteins/blood , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...